Oclacitinib (APOQUEL®) is a Novel Janus Kinase Inhibitor with Activity Against Cytokines Involved in Allergy, Mark Mitton-Fry, Andrea Gonzales, James Bowman, G. J. Fici, M. Zhang, Donald Wayne Mann
Chemistry Faculty Work